Risk Assessment of Micropollutants for Human and Environmental Health: Alignment with the Urban Wastewater Treatment Directive in Southeastern Spain

The reuse of reclaimed water is essential for sustainable water management in arid regions. However, despite advancements in Wastewater Treatment Plants (WWTPs), certain micropollutants may persist. To address these challenges, the recently enacted European Urban Wastewater Treatment Directive (UWWTD) has established strict standards focused on monitoring twelve specific indicator compounds. In line with this, the present study aims to evaluate the concentrations and potential risks of these twelve UWWTD-designated compounds across various water sources, including surface water, groundwater, and effluents from a WWTP in the southeast of Spain. Although none of the evaluated water sources are, as expected, intended for human consumption, risks were assessed based on worst-case scenarios that could amplify their impact. The study assessed potential risks to human health across different age groups and ecosystems, focusing on key organisms such as fish, daphnia, and algae, using empirical assessment approaches. The risk assessment identified a low risk for most compounds regarding human health, except for citalopram (HRQ = 19.116) and irbesartan (HRQ = 1.104), which showed high human risk quotients (HQR > 1) in babies, particularly in reclaimed water. In terms of ecotoxicological risk, irbesartan presented the highest ecological risk quotient (ERQ = 3.500) in fish, followed by clarithromycin, with algae (ERQ = 1.500) being the most vulnerable organism. Furthermore, compounds like citalopram, venlafaxine, and benzotriazole exhibited moderate ecological risks (ERQ between 0.1 and 1) in the reclaimed water, and their risk was reduced in surface water and groundwater. Finally, this study discussed the potential impacts of elevated concentrations of these emerging compounds, emphasizing the need for rigorous wastewater monitoring to protect human health and ecosystem integrity. It also revealed notable differences in risk assessment outcomes when comparing two distinct evaluation approaches, further highlighting the complexities of accurately assessing these risks.

Authors

Institutions

Publication Details

Journal
Toxics
Published
2025-04-04
DOI
https://doi.org/10.3390/toxics13040275
Citations
4
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk Assessment of Micropollutants for Human and Environmental Health: Alignment with the Urban Wastewater Treatment Directive in Southeastern Spain

Sofía Martínez-López, Isabel Martínez‐Alcalá, Agustín Lahora, Lissette Díaz-Gamboa et al.
4 citations
Toxics
Pharmaceutical and Antibiotic Environmental Impacts
2.01
article

Risk Assessment of Micropollutants for Human and Environmental Health: Alignment with the Urban Wastewater Treatment Directive in Southeastern Spain

Sofía Martínez-López, Isabel Martínez‐Alcalá, Agustín Lahora, Lissette Díaz-Gamboa, Luis Miguel Ayuso-García
article en
4 citations

Abstract

The reuse of reclaimed water is essential for sustainable water management in arid regions. However, despite advancements in Wastewater Treatment Plants (WWTPs), certain micropollutants may persist. To address these challenges, the recently enacted European Urban Wastewater Treatment Directive (UWWTD) has established strict standards focused on monitoring twelve specific indicator compounds. In line with this, the present study aims to evaluate the concentrations and potential risks of these twelve UWWTD-designated compounds across various water sources, including surface water, groundwater, and effluents from a WWTP in the southeast of Spain. Although none of the evaluated water sources are, as expected, intended for human consumption, risks were assessed based on worst-case scenarios that could amplify their impact. The study assessed potential risks to human health across different age groups and ecosystems, focusing on key organisms such as fish, daphnia, and algae, using empirical assessment approaches. The risk assessment identified a low risk for most compounds regarding human health, except for citalopram (HRQ = 19.116) and irbesartan (HRQ = 1.104), which showed high human risk quotients (HQR > 1) in babies, particularly in reclaimed water. In terms of ecotoxicological risk, irbesartan presented the highest ecological risk quotient (ERQ = 3.500) in fish, followed by clarithromycin, with algae (ERQ = 1.500) being the most vulnerable organism. Furthermore, compounds like citalopram, venlafaxine, and benzotriazole exhibited moderate ecological risks (ERQ between 0.1 and 1) in the reclaimed water, and their risk was reduced in surface water and groundwater. Finally, this study discussed the potential impacts of elevated concentrations of these emerging compounds, emphasizing the need for rigorous wastewater monitoring to protect human health and ecosystem integrity. It also revealed notable differences in risk assessment outcomes when comparing two distinct evaluation approaches, further highlighting the complexities of accurately assessing these risks.

ToxicsVol. 13(4)
Comunidad Autónoma de la Región de Murcia (ES), Universidad Católica de Murcia (ES)
Clean water and sanitation
Openalex Percentile: Top 15%
Pharmaceutical and Antibiotic Environmental Impacts
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.